OHI OMEGA HEALTHCARE INVESTORS INC Insider Trading

CIO Vikas Gupta purchases 11,500 OHI shares at $42.97, raising holdings 506% to 13,773 shares ($494.1K transaction)

Gupta, Chief Investment Officer, acquired 11,500 shares valued at $494,118.20, expanding his total position from 2,273 to 13,773 shares—a 505.9% net increase. The purchase price of $42.97 sits -1.6% below the 52-week high of $43.34 and within the current trading window, with the stock up 3.8% over 30 days and 6.7% over 90 days. OHI shows solid fundamentals with $311.6M quarterly revenue, $179.7M net income, and 10.7% annual revenue growth, trading at a 22.80 P/E ratio against a $12.6B market cap. The substantial increase in the CIO's personal stake merits observation for any context around capital deployment strategy or insider positioning relative to company performance.

OHI CEO Pickett C Taylor purchases 20,000 shares for $862.9K at $43.14, establishing new position

CEO Pickett C Taylor acquired 20,000 shares at $43.14 on 2025-11-05, establishing an initial position in OHI with a $862.9K purchase. The transaction executed near the 52-week high of $43.34, representing a material open-market commitment by the company's top executive. Against the company's strong fundamentals—revenue of $311.6M, net income of $179.7M, and annual revenue growth of +10.7%—this CEO purchase from a zero-position baseline signals a new alignment of interests. The stock's 30-day performance of +3.8% and 90-day performance of +6.7% provide context for the timing, though the absolute dollar commitment and executive rank merit investor tracking regardless of near-term price dynamics.

CFO Robert O Stephenson sold 22,542 shares of OHI at $40.19 for $905,962.98 on 2024-09-27; retains 183,076 shares.

Robert O Stephenson, Chief Financial Officer of Omega Healthcare Investors Inc, sold 22,542 shares on 2024-09-27 at $40.19, reducing his holdings by 11.0% to 183,076 shares post-transaction. The sale occurred near the 52-week high of $41.29, with the stock currently at $40.39 and up 19.5% over 90 days. Stephenson's cross-ticker track record shows 1 prior sell with an average 30-day return of +5.9%, though his timing pattern across all trades shows no measurable well-timed sells at the 90-day mark, limiting inference about predictive skill. The company reports strong fundamentals with $252.7M quarterly revenue, $117.1M net income, and 8.1% annual revenue growth, though a P/E of 30.83 reflects elevated valuation relative to historical context.

OHI COO Daniel J. Booth sold 56,725 shares at $40.25 on 2024-09-27, reducing holdings by 36.2%

Daniel J. Booth, COO of Omega Healthcare Investors, sold 56,725 shares at $40.25 for $2,283,181.25, reducing his holdings from 156,725 to 100,000 shares—a 36.2% reduction in position size. This represents a material divestiture that brings his remaining stake to 100,000 shares. The stock closed the transaction date within its 52-week range, 2.2% below the 52-week high of $41.29, and has appreciated 2.2% over 30 days and 19.5% over 90 days. While his cross-ticker track record shows 2 prior sells averaging +4.4% 30-day returns, his OHI-specific prior sales on 2024-09-05 and 2024-08-23 are still within their measurement windows with limited outcome data available. The fundamentals show a $10.4B market-cap company with $252.7M quarterly revenue, 8.1% annual revenue growth, and a P/E of 30.83—metrics suggesting reasonable operational performance. The substantial share reduction merits investor attention as a significant change in executive stake.

COO Daniel J Booth sold 25,000 shares of OHI at $40.06; holds 156.7K shares post-sale

Daniel J Booth, Chief Operating Officer, sold 25,000 shares at $40.06 on 2024-09-05, reducing his position from 181.7K to 156.7K shares (a 13.8% reduction). The sale occurred near the 52-week high of $39.99 and at a price above the current price of $39.64. Booth's cross-ticker track record shows 1 prior sell, with the outcome of prior sells at this specific ticker not yet measurable. The company reported $252.7M in latest quarterly revenue and $117.1M net income, with annual revenue growth of 8.1% and a P/E of 30.26. This is a standard open-market sale by a senior executive with a substantial continuing position; without measurable performance data on his prior OHI trades or broader timing patterns, the transaction does not present an unusual signal.

OHI CFO Stephenson sells 30,000 shares at $38.78; retains 205,618 shares post-sale.

Chief Financial Officer Robert O. Stephenson sold 30,000 shares of Omega Healthcare Investors on 2024-08-26 at $38.78, reducing his holdings by 12.7% to 205,618 shares. The sale occurred near the 52-week high of $39.27, with the stock having appreciated 8.2% over the prior 30 days and 27.6% over 90 days. The company reports strong fundamentals: $252.7M in latest quarterly revenue, $117.1M in net income, and 8.1% annual revenue growth, with a market cap of $10.1B. No FLAGS indicating a scheduled trading plan are present in the filing facts, suggesting this was a discretionary transaction by the CFO at a price point within the upper range of recent performance.

COO Daniel Booth sold 25,000 OHI shares at $38.71; holdings reduced to 181.7K shares

Daniel J Booth, Chief Operating Officer, executed an open-market sale of 25,000 shares at $38.71 on 2024-08-23, reducing his holdings from 206.7K shares to 181.7K shares—a -12.1% reduction in stake. The sale occurred near the company's 52-week high of $38.84, and the stock has appreciated 7.0% over the prior 30 days and 24.8% over 90 days, indicating strong recent momentum. The company's fundamentals remain solid with quarterly revenue of $252.7M, net income of $117.1M, annual revenue growth of +8.1%, and a market cap of $10.0B. This single discretionary sale by a key operating executive warrants monitoring to determine whether it reflects portfolio management or signals changing confidence in near-term prospects.